Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass
US7442383B2 · kind B2 · utility
4Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2003 |
| Grant date | Oct 28, 2008 |
| Priority date | — |
| Expiry date | May 1, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P41/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of controlling neurological deficits in patients who have undergone cardiopulmonary bypass (CPB) by administering xenon to said patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.